Chauvignac Cédric, Miller Carl N, Srivastava Sanjay K, Lewis John W, Husbands Stephen M, Traynor John R
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK.
J Med Chem. 2005 Mar 10;48(5):1676-9. doi: 10.1021/jm049172n.
Indolic N-benzylation of naltrindole reportedly extends the duration of delta-opioid receptor (DOR) antagonism. Similar modification of the kappa-opioid receptor (KOR) antagonist norBNI (1a) and its 17,17'-diNMe analogue (1d), a low potency mu-opioid receptor (MOR) partial agonist, was found to affect predominantly their MOR activity. When administered systemically in mouse antinociceptive assays, N-benzyl-norBNI (1b) had only MOR agonist activity of relatively short duration whereas on central administration it had only a KOR-antagonist action of extremely long duration.
据报道,纳曲吲哚的吲哚N-苄基化延长了δ-阿片受体(DOR)拮抗作用的持续时间。κ-阿片受体(KOR)拮抗剂norBNI(1a)及其17,17'-二甲基类似物(1d,一种低效μ-阿片受体(MOR)部分激动剂)的类似修饰被发现主要影响它们的MOR活性。在小鼠抗伤害感受试验中全身给药时,N-苄基-norBNI(1b)仅具有持续时间相对较短的MOR激动剂活性,而中枢给药时它仅具有持续时间极长的KOR拮抗作用。